Claritev Corporation (CTEV)

Market Cap	782.70M
Revenue (ttm)	927.45M
Net Income (ttm)	-1.18B
Shares Out	16.44M
EPS (ttm)	-74.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,505
Open	48.83
Previous Close	49.94
Day's Range	46.55 - 50.66
52-Week Range	4.80 - 51.29
Beta	0.57
Analysts	Buy
Price Target	44.00 (-7.6%)
Earnings Date	Jul 31, 2025

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 2,700
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2024, Claritev's revenue was $930.62 million, a decrease of -3.21% compared to the previous year's $961.52 million. Losses were -$1.65 billion, 1694.9% more than in 2023.

Analyst Summary

According to one analyst, the rating for CTEV stock is "Buy" and the 12-month stock price target is $44.0.

Price Target

$44.0

(-7.60% downside)

Analyst Consensus: Buy